VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditionsOsheiza Abdulmalik, Martin K. Safo, Jürgen Venitz et al.|Scientific Reports|2020Cited by 25
Inhibition of the Aquaporin-1 Cation Conductance by Selected Furan Compounds Reduces Red Blood Cell SicklingPak Hin Chow, Andrea J. Yool, Charles D. Cox et al.|Frontiers in Pharmacology|2022Cited by 13
Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell DiseaseRana T. Alhashimi, Martin K. Safo, Mohini S. Ghatge et al.|Biomolecules|2022Cited by 7
PP-14, a Novel Structurally-Enhanced Antisickling Allosteric Hemoglobin Effector, Increases Oxygen Affinity and Disrupts Hemoglobin S Polymer FormationMartin K. Safo, Osheiza Abdulmalik, Piyusha P. Pagare et al.|Blood|2019Cited by 1
Compound Nanoparticle 5HMF-Prodrug Formulations for Optimized Anti-Sickling TherapyStephen C. Rogers, Allan Doctor, Parikshit Moitra et al.|Blood|2022Cited by 0